92 results
Page 4 of 5
8-K
EX-99.1
96u0s8 3u882
27 Feb 20
Allogene Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
7:30am
S-3ASR
EX-1.2
6ad 28i1os7d
5 Nov 19
Automatic shelf registration
4:31pm
8-K
EX-99.1
e1luftyvowlh
5 Nov 19
Allogene Therapeutics Reports Third Quarter 2019 Financial Results
7:32am
8-K
EX-99.1
zu6x7m 814zs
7 Aug 19
Allogene Therapeutics Reports Second Quarter 2019 Financial Results
7:38am
8-K
EX-99.1
iezaj x6wdu6obq5fl8
7 May 19
Allogene Therapeutics Reports First Quarter 2019 Financial Results
8:36am
DEFA14A
84w5ffb3qnwj4i
24 Apr 19
Additional proxy soliciting materials
8:31am
DEF 14A
8wq pe84xt4h9sjij
24 Apr 19
Definitive proxy
8:01am
10-K
EX-10.18
20e0a0l5ya1c 5bm79fr
8 Mar 19
Annual report
4:02pm
10-K
lbxnod o6
8 Mar 19
Annual report
4:02pm
10-K
EX-10.17
iq9v2npusvfz9m
8 Mar 19
Annual report
4:02pm
8-K
EX-99.1
fv7 90caid
8 Mar 19
Allogene Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
8:10am
10-Q
928m xhc08
21 Nov 18
Quarterly report
4:31pm
S-8
EX-99.2
0jb4j2iw qsrjhbh54
24 Oct 18
Registration of securities for employees
4:08pm
8-K
EX-3.2
i3npi jet3cwpd3c8q
15 Oct 18
Allogene Therapeutics Announces Closing of Initial Public Offering
5:28pm
424B4
arz3j kjmo
11 Oct 18
Prospectus supplement with pricing info
5:24pm